Table 5.
The number of women who had each cotest result prior to one, two and three negative cotests, and the number and percentage of women diagnosed with CIN2+ by the prior cotest result
| Cytology result at test preceding one negative cotest | n | CIN2+ (n) | CIN2+ (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV result at test preceding one negative cotest | ||||||||||||
| HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | |
| NILM | 58,166 | 22,035 | 799 | 81,000 | 33 | 19 | 5 | 57 | 0.057 | 0.086 | 0.626 | 0.070 |
| N/a* | 1,431 | – | 5 | 1,436 | 2 | – | 0 | 2 | 0.140 | 0.000 | 0.139 | |
| ASCUS | 274 | 106 | 372 | 752 | 0 | 0 | 2 | 2 | 0.000 | 0.000 | 0.538 | 0.266 |
| LSIL | 74 | 8 | 125 | 207 | 1 | 0 | 0 | 1 | 1.351 | 0.000 | 0.000 | 0.483 |
| High‐grade | 159 | 9 | 49 | 217 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| Total | 60,104 | 22,158 | 1,350 | 83,612 | 36 | 19 | 7 | 62 | 0.060 | 0.086 | 0.519 | 0.074 |
| ASCUS+ | 507 | 123 | 546 | 1,176 | 1 | 0 | 2 | 3 | 0.197 | 0.000 | 0.366 | 0.255 |
| Cytology result at test preceding two negative cotests | HPV result at test preceding two negative cotests | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | |
| NILM | 18,858 | 9,210 | 486 | 28,554 | 9 | 2 | 1 | 12 | 0.048 | 0.022 | 0.206 | 0.042 |
| N/a* | 597 | – | 12 | 609 | 1 | 0 | 1 | 0.168 | 0.000 | 0.164 | ||
| ASCUS | 925 | 121 | 75 | 1,121 | 1 | 0 | 0 | 1 | 0.108 | 0.000 | 0.000 | 0.089 |
| LSIL | 35 | 11 | 16 | 62 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| High‐grade | 37 | 3 | 7 | 47 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| Total | 20,452 | 9,345 | 596 | 30,393 | 11 | 2 | 1 | 14 | 0.054 | 0.021 | 0.168 | 0.046 |
| ASCUS+ | 997 | 135 | 98 | 1,230 | 1 | 0 | 0 | 1 | 0.100 | 0.000 | 0.000 | 0.081 |
| Cytology result at test preceding three negative cotests | HPV result at test preceding three negative cotests | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | HPV negative | N/a* | HPV positive | Total | |
| NILM | 2,434 | 2011 | 69 | 4,514 | 1 | 0 | 0 | 1 | 0.041 | 0.000 | 0.000 | 0.022 |
| N/a* | 58 | 2 | 60 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | |||
| ASCUS | 89 | 27 | 2 | 118 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| LSIL | 3 | 1 | 1 | 5 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| High‐grade | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | ||
| Total | 2,590 | 2039 | 74 | 4,703 | 1 | 0 | 0 | 1 | 0.039 | 0.000 | 0.000 | 0.021 |
| ASCUS+ | 98 | 28 | 3 | 129 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
Abbreviations: NILM, negative for intraepithelial lesions or malignancy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low‐grade squamous intraepithelial lesion.
*This test was not carried out.